North America:
The North America corneal transplant market is driven by a high prevalence of corneal diseases and significant advancements in transplant techniques. The region benefits from a well-established healthcare infrastructure, extensive donor tissue availability, and strong awareness among both patients and healthcare providers. The United States leads the market, supported...